Assoc Prof Philip Eng, senior consultant respiratory physician at Mt Elizabeth Hospital in Singapore, shares his insights with Pearl Toh on diagnosing and managing pneumonia in the primary care setting.
In mid-March 2019, news of the Sungai Kim Kim chemical pollution disaster and its impact on thousands of Johor residents caught national attention. As healthcare services rushed in to provide medical aid, a temporary command centre was set up at Pasir Gudang Indoor Stadium to centralize efforts. MIMS Pharmacist spoke to three pharmacists about their experiences as volunteers there.
Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.
The eighth most common cancer among women in Singapore, the incidence of thyroid cancer has increased exponentially in the past decades. Fortunately, the most common types of thyroid cancer carry an excellent prognosis and are rarely the cause of mortality if detected early and treated.
Non-alcoholic fatty liver disease (NAFLD) – a clinicopathological spectrum comprising hepatic steatosis or non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) – is the hepatic manifestation of metabolic syndrome recognized as a leading cause of liver morbidity and mortality. Dr Loo Wai Mun, Consultant at the Division of Gastroenterology and Hepatology, National University Hospital, Singapore, speaks with Audrey Abella to discuss how NAFLD can be best managed in primary care.
April 17 marks World Haemophilia Day, and this year’s theme is “Reaching Out – The First Step to Care”. Adjunct Assoc Prof Joyce Lam Ching Mei, head of the Haematology Laboratory and Blood Bank and senior consultant from the Paediatric Haematology/Oncology Service at KK Women’s and Children’s Hospital, Singapore, speaks to Elaine Soliven on the importance of recognizing and managing bleeding disorders in primary care.
At the recent forum “Improving Access to Affordable Cancer Treatments in Malaysia”, the issue of treatment costs was discussed by panellists from the Ministry of Health (MOH) and pharmaceutical industry representatives.
MIMS Pharmacist speaks to Dr Renly Lim, Universiti Sains Malaysia (USM) 2016 postgraduate and current research fellow at the University of South Australia (UniSA), about her current work in geriatric care and her academic history.
Dr Ong Kian Chung, a respiratory specialist at the KC Ong Chest & Medical Clinic, Mount Elizabeth Medical Centre, Singapore spoke on the evils of tobacco use and how clinicians can help in smoking cessation.
In the blink of an eye, Malaysia has passed the threshold a young nation to one that is ageing. We are due to reach this status in 2020, where the projected population aged 65 and older is 7.2 percent. The UN defines an ageing society as one that has a minimum of 7 percent of the population aged 65 and older while an aged nation has 14 percent or more in the same age group.
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Despite a 90-percent cure rate after first treatment for children with acute lymphoblastic leukaemia (ALL), approximately 10–15 percent of patients with paediatric ALL will experience relapse. [Expert Rev Anticancer Ther 2017;17:725-736] A recent webinar on the current landscape of ALL highlighted the potential of immunotherapy for paediatric patients with relapsed or refractory ALL, thus providing hope for this high-risk patient group.